# PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

> **NCT01975961** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 185 (actual)

## Conditions studied

- Dyslipidemia & Hypertension

## Interventions

- **DRUG:** Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC

## Key facts

- **NCT ID:** NCT01975961
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975961, "PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01975961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*